This article was originally presented as an independent educational activity under the direction of CME LLC. The ability to receive CME credits has expired. The article is now presented here for your reference. CME LLC is no longer responsible for the presentation of the article.
A 30-year-old man is admitted for profound, symptomatic anemia. He has become weaker and more tired and fatigued in recent weeks. In the days before admission, dyspnea with minimal effort developed as well. He denies hemoptysis, melena, hematochezia, or other bleeding. He also denies fever and signs of bleeding, such as petechiae, purpura, or ecchymoses.
The patient had been reasonably healthy until several months before this admission. Since then he has lost more than 11 kg (about 25 lb), and he now weighs 54.5 kg (120 lb). Although his appetite has been diminished, he has had no specific GI symptoms, such as abdominal pain or changes in bowel habits. He went to the public health clinic, where a battery of blood tests was ordered, but he has not returned to find out the results.
He is currently unemployed and lives in an apartment with his brother. He has a history of intravenous use of both heroin and cocaine.
This thin man looks older than his stated age. Heart rate at rest is 110 beats per minute. Temperature and blood pressure are normal. Mucosae are very pale. Diffuse 1-cm lymph nodes are palpable bilaterally in the anterior cervical areas. Lungs are clear. Abdomen is soft, without masses or hepatosplenomegaly. No rashes are evident, and results of a neurological examination are normal.
Hemoglobin level is 3.9 g/dL; hematocrit, 15 mL/dL; and mean corpuscular volume, 104 fL. Platelet count is 151,000/µL. White blood cell count is 3500/µL, with 89% segmented neutrophils, 4% monocytes, and 7% lymphocytes. Smear reveals moderate anisocytosis but is otherwise morphologically normal. Results of routine chemistry and biochemical panels are normal.
Which of the following represents optimal management for this patient?
1. Shih A, Kassanoff RE, Altrabulsi B. Severe anemia. Baylor Univ Med Center
2. Gottlieb F, Deutsch J. Red cell aplasia responsive to immunoglobulin therapy
as initial manifestation of human immunodeficiency virus infection. Am J Med.
3. Arribas JR, Peña JM, Echevarría JE. Parvovirus B19-related anemia in an
HIV-infected patient: rapid control after production of neutralizing antibodies
during highly active antiretroviral therapy. Ann Intern Med. 2000;132:1011.
4. Young NS, Brown KE. Parvovirus B19. N Engl J Med. 2004;350:586-597.